Clinical Trials Logo

Neurocognitive Disorders clinical trials

View clinical trials related to Neurocognitive Disorders.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 2

NCT ID: NCT03628768 Active, not recruiting - Clinical trials for Neurocognitive Disorders

Risk Factors for Falls and Neurocognitive Disorders CLSA

Start date: July 23, 2019
Phase:
Study type: Observational [Patient Registry]

The study evaluates the association between the neurocognitive decline and falls.

NCT ID: NCT03540433 Active, not recruiting - Clinical trials for Neurocognitive Disorders

International Observational Study on Perioperative Cognitive Trajectories (POCD Census International/PCI)

Start date: June 8, 2018
Phase:
Study type: Observational

The purpose of this international, multi-centre observational study is to describe perioperative cognitive changes (pre-existing neurocognitive disorder [NCD], postoperative delirium [POD] and Postoperative Cognitive Dysfunction [POCD]) up to five years after elective surgery in a mixed cohort. Measurements and definitions of cognitive outcomes will be based on current consensus and used for further harmonization in future clinical studies on perioperative cognitive trajectories. This is a feasibility approach to identify an effective screening procedure and estimate loss to follow up rates for the planning of future intervention studies. Data from this trial may also serve to facilitate and implement time effective cognitive screening and risk stratification concerning postoperative cognitive decline in the anaesthesiological preoperative assessment.

NCT ID: NCT03514095 Active, not recruiting - Dementia Clinical Trials

Cognitive Stimulation in the Elderly: Individual Intervention on Cognitive Frailty

ECOG_CS
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Cognitive Stimulation (CS) in the elderly, as a group intervention, shows benefits on the cognition and quality of life of people with neurocognitive disorder (NCD)(ie, dementia). The evidence of cognitive stimulation as an individualized intervention, conducted at home, by the caregiver is limited. The main objective of this trial is to evaluate the effectiveness of the Individual Cognitive Stimulation Therapy program - "Making a Difference 3 - individual Cognitive Stimulation Therapy (MD3), its acceptability and applicability by the dyad (people with NCD and their caregiver) in the Portuguese population. To achieve this purpose a pilot study will be conducted (randomized control trial), with two moments of evaluation - before the intervention of individual cognitive stimulation and after the intervention in both groups (Group 1 - group subject to intervention: individual cognitive stimulation program called "MD3"; Group 2 - group subject to usual care).The investigators intend to know the effect of the program on cognitive domains, quality of life and relationship between caregiver and care recipient. And, as well as understand the acceptability and applicability of the program by participants (dyad).

NCT ID: NCT03069391 Active, not recruiting - Aging Clinical Trials

The Interactive Physical and Cognitive Exercise System

iPACES™
Start date: March 4, 2017
Phase: N/A
Study type: Interventional

This study is intended to clarify the benefits to brain health and thinking processes that result from different forms of exercise. In particular, this study will investigate the possible benefits of physical exercise (such as pedaling an under-table stationary elliptical) or mental exercise (such as playing a videogame on a portable tablet), or combining these activities together (as in the iPACES™ exergame).

NCT ID: NCT02958670 Active, not recruiting - Healthy Clinical Trials

Imaging Tau Deposition in the Brain of Elderly Subjects

Add-Tau
Start date: November 2016
Phase: N/A
Study type: Interventional

Cerebral accumulation of tau and beta-amyloid are major factors of Alzheimer's disease pathology. A novel Positron Emission Tomography (PET) tracer (18-F-AV-1451) now offers the ability to study tau protein deposition in vivo in subjects, in which information on cerebral amyloid deposition has already been gathered. This enables to study effects of tau deposition on neuronal integrity, their relation to effects of beta-amyloid deposition and how this contributes to cognitive impairment or well-being in the elderly.